| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross Margin | 4.62% | 21.00% | 23.32% | 38.78% | 27.00% |
| Operating Margin | -433.49% | -26.29% | -66.19% | -143.41% | -211.61% |
| EBITDA Margin | -431.86% | -25.00% | -62.93% | -136.34% | -206.04% |
| Net Margin | -335.61% | -26.73% | -74.98% | -141.59% | -237.87% |
| Current Ratio | 1.01 | 1.05 | 1.31 | 1.79 | 7.84 |
| Quick Ratio | 0.79 | 0.74 | 0.79 | 1.21 | 7.34 |
| Debt / Equity | 0.76 | 0.46 | 0.30 | 0.02 | 0.00 |
| ROE | -169.71% | -352.71% | -890.63% | -93.29% | -27.76% |
| ROA | -91.94% | -60.65% | -241.41% | -64.98% | -24.99% |
| Asset Turnover | 0.27 | 2.27 | 3.22 | 0.46 | 0.11 |
| Book Value / Share | 25627.32 | 367.65 | 870.58 | 14721.29 | 1174.37 |
ZeroStack Corp. is a Nasdaq-listed asset management company specializing in decentralized AI investments. Formerly known as Flora Growth Corp., it rebranded in January 2026 to reflect its strategic pivot toward AI-focused asset management, marking it as the first publicly traded firm providing exposure to this emerging sector. The company holds approximately 123 million $0G tokens, the native asset of the 0G decentralized AI operating system, employing a concentrated digital asset strategy to generate yield and fee-based income through staking validators, compute power technology firms, and complementary businesses in the $0G ecosystem and broader AI landscape. Headquartered in Toronto, Ontario, Canada, with operations including a global pharmaceutical distribution subsidiary, Phatebo GmbH, ZeroStack Corp. maintains a market capitalization around $10-12 million, recent trailing twelve-month revenue of $57.61 million (up 24.7%), and continues to evolve under CEO Daniel Reis-Faria's leadership since its founding in 2019.